1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Robert J. Porte: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation Dual hypothermic oxygenated perfusion, Liver Assist®, Perfusion fluid - Liver Failure, End Stage Liver Disease | Phase 3 | Completed | Robert J. Porte | 157 | 2016-01-01 | 2021-01-12 |
Biliary Tract Diseases (1) · End Stage Liver Disease (1) · Liver Failure (1)
Glutathione (1) · newcastle organ perfusion fluid (1)
Belgium (1) · Netherlands (1) · United Kingdom (1)
Robert J. Porte, MD PhD Prof (1)
PMID 30866837, PMID 31420387, PMID 33626248, PMID 39853733, PMID 41082480